DESCRIÇÃO:
OEA ( Oleoyethanolamide) : Composto natural derivado a partir do ácido oleico e produzido no intestino delgado. Desempenha um papel fundamental em mecanismos cerebrais que regula a ingestão de alimentos e o gasto de energia.
OEA® não age no cérebro, mas sim desencadeia um sinal separado que afeta a fome e o comportamento alimentar. OEA® trabalha ativando receptores PPAR e simultaneamente aumenta a queima de gordura e diminui o armazenamento de gordura.
Exerce seus efeitos principalmente através da estimulação de aferentes do nervo vago no trato gastrointestinal (TGI), estabelecendo a comunicação do eixo intestino-cérebro e promovendo a regulação da homeostase energética, o catabolismo de ácidos graxos e a lipogênese em resposta a sensação de fome e saciedade.
Desta forma, evidências têm demonstrado que a suplementação com OEA modula o metabolismo energético celular e contribui para a redução do apetite, bem como auxilia no gerenciamento do peso corporal.
INDICAÇÃO:
Auxiliar em dietas de emagrecimento, aumentando a queima de gorduras e diminuição do apetite,
MODO DE USO:
Ingerir uma cápsula duas vezes ao dia 15 a 30,minutos antes das principais refeições. Ingerir com bastante água.
COMPOSIÇÃO:
OEA ( Oleoyethanolamide) 200mg
Excipiente qsp 1 cápsula
VALIDADE:
6 meses.
VENDA SOB PRESCRIÇÃO DE PROFISSIONAL HABILITADO, PODENDO SER NOSSA FARMACÊUTICA, RESOLUÇÃO 586/2013 - CONSELHO DE FARMÁCIA
BIBLIOGRAFIA:
1. Serrano A, et al Oleoylethanolamide: effects on hypothalamic transmitters and gut peptides regulating food intake. Neuropharmacology (2011)
2. Petrosino S, Di Marzo V Anandamide and Other Acylethanolamides . Handbook of Neurochemistry and Molecular Neurobiology. (2010)
3. Fu J, et al Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha . Nature. (2003)
4. Thabuis C, et al Biological functions and metabolism of oleoylethanolamide . Lipids. (2008)
5. Cadas H, di Tomaso E, Piomelli D Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidyletha-nolamine, in rat brain . J Neurosci. (1997)
6. Di Marzo V, et al Formation and inactivation of endogenous cannabinoid anandamide in central neurons . Nature. (1994)
7. Cravatt BF, et al Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides . Nature. (1996)
8. Gaetani S, Oveisi F, Piomelli D Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide . Neuropsychopharmacology. (2003)
9. Lauffer LM, Iakoubov R, Brubaker PL GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell . Diabetes. (2009)
10. Overton HA, et al Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents . Cell Metab. (2006)
11. Ryberg E, et al The orphan receptor GPR55 is a novel cannabinoid receptor . Br J Pharmacol. (2007)
12. Begg M, et al Evidence for novel cannabinoid receptors . Pharmacol Ther. (2005)
13. Petitet F, Donlan M, Michel A GPR55 as a new cannabinoid receptor: still a long way to prove it . Chem Biol Drug Des. (2006)
14. Cluny NL, et al The identification of peroxisome proliferator-activated receptor alpha-independent effects of oleoylethanolamide on intestinal transit in mice . Neurogastroenterol Motil. (2009)
15. Nielsen MJ, et al Food intake is inhibited by oral oleoylethanolamide . J Lip Res. (2004)
16.Schmid PC, Zuzarte-Augustin ML, Schmid HH Properties of rat liver N-acylethanolamine amidohydrolase . J Biol Chem. (1985)
17. Katayama K, et al Distribution of anandamide amidohydrolase in rat tissues with
special reference to small intestine . Biochim Biophys Acta. (1997)
18.Cox JE, et al Suppression of food intake, body weight, and body fat by jejunal fatty acid infusions . Am J Physiol Regul Integr Comp Physiol. (2000)
19. Murillo-Rodríguez E, et al Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats . PLoS One. (2011)
20. Arletti R1, Benelli A, Bertolini A Influence of oxytocin on feeding behavior in the rat . Peptides. (1989)
21. Deblon N1, et al Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats . PLoS One. (2011)
22. Zhang G1, et al Neuropeptide exocytosis involving synaptotagmin-4 and oxytocin in hypothalamic programming of body weight and energy balance . Neuron. (2011)
23. Gimpl G1, Fahrenholz F The oxytocin receptor system: structure, function, and regulation . Physiol Rev. (2001)
24. Gaetani S, et al The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin . J Neurosci. (2010)
25. Martin G, et al Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARal-pha and PPARgamma activators . J Biol Chem. (1997)
26. Escher P, et al Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding . Endocrinology. (2001)
27. Rodríguez de Fonseca F, et al An anorexic lipid mediator regulated by feeding . Nature. (2001)
28. Little TJ, Horowitz M, Feinle-Bisset C Role of cholecystokinin in appetite control and body weight regulation . Obes Rev. (2005)
29. Batterham RL, Bloom SR The gut hormone peptide YY regulates appetite . Ann N Y Acad Sci. (2003)
30. Jin P, et al Antidepressant-like effects of oleoylethanolamide in a mouse model of chronic unpredictable mild stress . Pharmacol Bio-chem Behav. (2015)
31. Suárez J, et al Oleoylethanolamide enhances β-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epidi-dymal white adipose tissue in rat . Dis Model Mech. (2014)
32. Bachman ES, et al betaAR signaling required for diet-induced thermogenesis and obesity resistance . Science. (2002)
33. White CL, et al Effect of a beta-3 agonist on food intake in two strains of rats that differ in susceptibility to obesity . Physiol Behav. (2004)
34. Dallner OS, et al Beta3-adrenergic receptors stimulate glucose uptake in brown adipocytes
by two mechanisms independently of glu-cose transporter 4 translocation .
Endocrinology. (2006)
:quality(80)/seivaman/catalog/banners/ban12.png "Seiva Manipulação | Produtos Naturais e Medicamentos")
:quality(80)/seivaman/catalog/2023/06-04/seiva-embalagem-2023-04-04-4.jpg "OEA (Oleoyethanolamide) 30cápsulas")
:quality(80)/seivaman/catalog/2023/06-04/seiva-embalagem-2023-04-04-4.jpg "OEA (Oleoyethanolamide) 30cápsulas")
:quality(80)/seivaman/catalog/loja/payment-method-footer.png "Mais formas de pagamento")